CTD-O 12.5/20 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Chlorthalidone (12.5mg)
Overview CTD-O 12.5/20 Tablet
CTD-O 12.5/20 tablets combine two medications to manage hypertension through complementary mechanisms. Untreated hypertension significantly increases the risk of stroke, heart attack, and kidney disease. This medication can be taken with or without food; dosage is individualized based on your response and health status. Consistent daily timing is recommended. Continue taking this medication as directed by your physician. The diuretic component may increase urination, so avoid dosing within four hours of bedtime. Regular use, even during asymptomatic periods, is crucial for optimal blood pressure control; discontinuation raises the risk of cardiovascular events. Dizziness is the most frequent adverse effect; others include fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is expected due to the chlorthalidone component and contributes to blood pressure regulation. While other side effects are possible, most are uncommon. Consult the patient information leaflet and inform your doctor of any persistent or bothersome side effects; dosage adjustments or alternative treatments may be considered. This medication is generally not recommended during pregnancy and requires consultation with your doctor if you have kidney or liver impairment, heart conditions, or diabetes. Alcohol consumption may exacerbate hypotension and side effects.
Uses of CTD-O 12.5/20 Tablet
Elevated blood pressure
Major Benefits of CTD-O 12.5/20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-O 12.5/20 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of CTD-O 12.5/20 Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use CTD-O 12.5/20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. CTD-O 12.5/20 Tablets can be consumed with or without food, although consistent timing is recommended.
How CTD-O 12.5/20 Tablet works:
The tablet CTD-O 12.5/20 is a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of CTD-O 12.5/20 tablets and alcohol may result in significant drowsiness.
PregnancyCONSULT YOUR DOCTOR
Using CTD-O 12.5/20 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should only be considered in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known dangers, as determined by a physician. Always seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of CTD-O 12.5/20 Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a CTD-O 12.5/20 Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering CTD-O 12.5/20 Tablet to individuals with severely impaired renal function; dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with such conditions.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using CTD-O 12.5/20 tablets, potentially requiring dosage modification. Medical advice is necessary. The use of CTD-O 12.5/20 tablets is contraindicated in patients with severe liver dysfunction.
What if you forget to take CTD-O 12.5/20 Tablet :
Should you forget to take a CTD-O 12.5/20 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD-O 12.5/20 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Heart |




